Rare diseases
Investigational molecules
Locations
Study of risankizumab safety and effectiveness in children and teenagers aged 2-17 years with moderate to severe ulcerative colitis
SwedenStudy of Glofitamab and Pirtobrutinib Treatment in Patients with Mantle Cell Lymphoma Who Have Failed Previous Therapy and in Previously Untreated Patients
SwedenStudy of drug combination therapy in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma using odronextamab, loncastuximab tesirine and rituximab
SwedenStudy of pivmecillinam compared to standard antibiotics for treating Escherichia coli urinary tract infection with fever
SwedenStudy of trospium chloride and xanomeline tartrate (KarXT) for treating manic episodes in adults with bipolar I disorder
SwedenStudy of sacituzumab tirumotecan, pembrolizumab and chemotherapy combination for early-stage triple-negative breast cancer or hormone receptor-low positive/HER2-negative breast cancer
SwedenStudy of RSVPreF3 vaccine with AS01E adjuvant in adults aged 60-65 and over 80 years to prevent respiratory syncytial virus infection
SwedenStudy of Nucresiran in Adults with Transthyretin Amyloidosis with Cardiomyopathy to Evaluate its Effects on Survival and Heart Problems
SwedenLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
SwedenStudy comparing daratumumab, lenalidomide and dexamethasone followed by linvoseltamab versus continued initial treatment in newly diagnosed multiple myeloma patients
SwedenStudy of BMS-986504 for patients with advanced or metastatic non-small cell lung cancer with homozygous MTAP deletion who have previously received treatment
SwedenStudy of SAR444336 in Adults with Microscopic Colitis Who Achieved Clinical Remission with Budesonide Treatment
SwedenTell us about your condition – we search every trial in Europe and connect you with the right site.
